Horizon Pharma Public Limited Company (HZNP)
(Delayed Data from NSDQ)
$26.54 USD
+0.55 (2.12%)
Updated May 3, 2019 04:00 PM ET
After-Market: $26.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMRevenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Sales: Vimovo [$M] |
-- | -- | 2 | 8 | 38 | 52 |
Sales: Duexis [$M] |
-- | -- | 5 | 74 | 125 | 116 |
Sales: Tepezza [$M] |
-- | -- | 1,966 | 1,661 | 820 | -- |
Sales: Krystexxa [$M] |
-- | -- | 716 | 565 | 406 | 342 |
Sales: Ravicti [$M] |
-- | -- | 326 | 292 | 262 | 229 |
Sales: Procysbi [$M] |
-- | -- | 210 | 190 | 170 | 162 |
Sales: Uplizna [$M] |
-- | -- | 155 | 61 | -- | -- |
Sales: Actimmune [$M] |
-- | -- | 126 | 117 | 119 | 107 |
Sales: Buphenyl [$M] |
-- | -- | 7 | 8 | 11 | 10 |
Sales: Quinsair [$M] |
-- | -- | 1 | 1 | 1 | 1 |
Sales: Pennsaid [$M] |
-- | -- | 74 | 192 | 178 | 201 |